We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Devicemakers Question Value of CMS, FDA Parallel Review
The item has been added to your shopping cart.
Devicemakers Question Value of CMS, FDA Parallel Review
December 30, 2010
Despite claims by the FDA and Centers for Medicare & Medicaid Services (CMS) that parallel review could expedite marketing of new devices, industry fears the opposite could happen, depending on how the program is implemented.